2 Coronavirus Stocks Robinhood Investors Love. Should You?

Robinhood Markets is a financial services company that owns the stock-trading app Robinhood, which is highly popular among millennials. The company has made a habit of maintaining an updated list of the 100 most popular stocks on its platform.

A peek at the stocks in the most recent ranking (as of this writing) reveals that Robinhood investors have been busy buying shares of companies that are involved in the development of vaccines or treatments for the coronavirus. In particular, Gilead Sciences (NASDAQ: GILD) and Sorrento Therapeutics (NASDAQ: SRNE) both feature on the list.

Gilead Sciences is the biotech behind remdesivir, an antiviral drug that could be our best shot at a treatment for COVID-19. Meanwhile, Sorrento Therapeutics boasts several coronavirus-related products in its pipeline. Both of these companies have handily outperformed the market of late, but will they continue to do so? Let's look at each and figure out whether they deserve a place in your portfolio. 

Continue reading

Source Fool.com